Samsung Biologics (207940) stock
Samsung Biologics technical analysis
Oscillators
Summary
Moving averages
| Oscillators | Value | Signal |
|---|---|---|
| RSI (14) | 33.26 | Neutral |
| Stochastic %K (14, 3, 3) | 28.45 | Neutral |
| CCI (20) | -207.59 | Neutral |
| ADX (14) | 24.24 | Sell |
| Awesome Oscillator | -86,258.46 | Sell |
| Momentum (10) | -86,000 | Sell |
| MACD (12, 26) | -34,820.11 | Sell |
| Stoch RSI (3, 3, 14, 14) | 48.66 | Neutral |
| Williams %R (14) | -92.75 | Buy |
| Bull Bear Power | -107,518.37 | Sell |
| Ultimate Oscillator (7, 14, 28) | 42.28 | Neutral |
| Moving averages | Value | Signal |
|---|---|---|
| EMA (10) | ₩1,375,847.45 | Sell |
| SMA (10) | ₩1,376,961.15 | Sell |
| EMA (20) | ₩1,404,645.33 | Sell |
| SMA (20) | ₩1,402,480.58 | Sell |
| EMA (30) | ₩1,423,094.39 | Sell |
| SMA (30) | ₩1,448,453.72 | Sell |
| EMA (50) | ₩1,439,099.65 | Sell |
| SMA (50) | ₩1,477,672.23 | Sell |
| EMA (100) | ₩1,463,162.37 | Sell |
| SMA (100) | ₩1,424,906.12 | Sell |
| EMA (200) | ₩1,509,162.33 | Sell |
| SMA (200) | ₩1,547,433.06 | Sell |
| Ichimoku Base Line (9, 26, 52, 26) | ₩1,455,500.00 | Sell |
| VWMA (20) | ₩1,395,564.03 | Sell |
| Hull MA (9) | ₩1,362,778.00 | Sell |
Support & resistance levels
Resistance
- R2₩1,737,415.63+32.63%Weak
- R1₩1,544,780.42+17.92%Strong
Support
- S1₩1,302,064.89-0.61%Moderate
- S2₩1,258,000.00-3.97%Weak
- S3₩1,228,000.00-6.26%Weak
Levels are detected automatically from swing highs and lows on the daily chart and clustered by volatility (ATR). Strength reflects the number of times price reacted at each level.
| Pivot points (daily) | S3 | S2 | S1 | P | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | ₩1,247,333.33 | ₩1,298,666.67 | ₩1,326,333.33 | ₩1,377,666.67 | ₩1,405,333.33 | ₩1,456,666.67 | ₩1,484,333.33 |
| Fibonacci | ₩1,298,666.67 | ₩1,328,844.67 | ₩1,347,488.67 | ₩1,377,666.67 | ₩1,407,844.67 | ₩1,426,488.67 | ₩1,456,666.67 |
| Camarilla | ₩1,332,275.00 | ₩1,339,516.67 | ₩1,346,758.33 | ₩1,377,666.67 | ₩1,361,241.67 | ₩1,368,483.33 | ₩1,375,725.00 |
| Woodie | ₩1,235,500.00 | ₩1,292,750.00 | ₩1,314,500.00 | ₩1,371,750.00 | ₩1,393,500.00 | ₩1,450,750.00 | ₩1,472,500.00 |
| DeMark | — | — | ₩1,312,500.00 | ₩1,370,750.00 | ₩1,391,500.00 | — | — |
Samsung Biologics price forecast
| Horizon | Bear case (95%) | Low (68%) | Trend target | High (68%) | Bull case (95%) |
|---|---|---|---|---|---|
| 5 trading days | ₩1,148,021.72 | ₩1,225,725.50 | ₩1,308,688.66 -0.1% | ₩1,397,267.18 | ₩1,491,841.12 |
| 21 trading days | ₩997,383.99 | ₩1,140,652.71 | ₩1,304,501.19 -0.4% | ₩1,491,885.61 | ₩1,706,186.77 |
| 63 trading days | ₩812,577.42 | ₩1,025,245.33 | ₩1,293,572.73 -1.3% | ₩1,632,126.82 | ₩2,059,287.35 |
The technical bias for Samsung Biologics is bearish (overall rating: Strong Sell).
Bullish scenario: a sustained break above ₩1,544,780.42 would open the way toward ₩1,737,415.63.
Bearish scenario: a daily close below ₩1,302,064.89 could extend the decline toward ₩1,258,000.00.
Statistical ranges are based on historical volatility and trend, not a guarantee of future prices. Not financial advice.
About Samsung Biologics
Samsung Biologics (207940) shares are trading at ₩1,310,000.00, down -3.25% today. The company belongs to the Health Care sector and has a market capitalization of ₩60.99T.
The stock’s 52-week range is ₩1,228,000.00 – ₩1,987,000.00, with a price-to-earnings ratio of —. It has moved -3.42% over the past week and -12.31% over the past month.
On the daily chart the overall technical rating for Samsung Biologics is Strong Sell, with the 14-day RSI at 33.3. The nearest support is at ₩1,302,064.89 and the nearest resistance at ₩1,544,780.42.
Related markets
AllStock market news
-
Trump waives rules on red-dyed diesel, but local tax and other concerns remainMarketWatch.com34 min. ago
-
JPMorgan reveals stocks worth buying in October 2026Yahoo Finance35 min. ago
-
Q2 Rundown: GE Vernova (NYSE:GEV) Vs Other Electrical Systems StocksYahoo Finance36 min. ago
-
3 Growth Stocks to Buy Instead of SpaceXYahoo Finance58 min. ago
-
U.S. stocks rise toward an all-time high after oil prices easePittsburgh Post-Gazette59 min. ago
-
‘Trump accounts’ could force MAGA children to own New York Times stockMarketWatch.com1 hr. ago